Literature DB >> 12219870

Positive association between circulating free insulin-like growth factor-1 levels and coronary flow reserve in arterial systemic hypertension.

Maurizio Galderisi1, Pio Caso, Silvana Cicala, Luigi De Simone, Michelangela Barbieri, Giovanni Vitale, Oreste de Divitiis, Giuseppe Paolisso.   

Abstract

BACKGROUND: The reduction of coronary flow reserve (CFR) found in arterial hypertension may be due to changes in afterload, left ventricular (LV) structure, and metabolic factors. Also, insulin-like growth factor-1 (IGF-1) may be associated with the magnitude of CFR in relation to its modulating action on cardiac and endothelial function.
METHODS: A total of 44 newly diagnosed, untreated hypertensive patients, who were free of diabetes mellitus and coronary artery disease, underwent M-mode analysis, second-harmonic Doppler echocardiographic assessment of CFR (dipyridamole infusion 0.56 mg/kg intravenously in four patients), determination of circulating free IGF-1, and insulin resistance. Based on CFR levels, hypertensive subjects were divided into two groups: 18 with normal CFR (> or = 2) and 26 with impaired CFR (<2).
RESULTS: Patients with normal CFR had lower diastolic blood pressure, heart rate, and LV mass index but higher free circulating IGF-I than patients with reduced CFR (P < .001). Insulin resistance was not significantly different between the two groups. In a first multilinear regression analysis that included demographic and echocardiographic variables, insulin resistance was independently associated with CFR (standardized beta coefficient = -0.31, P < .05) in the overall population. However, in a subsequent model which included also IGF-1, the relationship between insulin resistance and CFR disappeared, whereas IGF-1 was the main independent determinant of CFR (beta = 0.51, P < .0002).
CONCLUSIONS: Free IGF-1 circulating levels are independently associated with CFR in hypertensive individuals free of overt coronary artery disease. A possible beneficial effect exerted by IGF-1 on coronary blood flow may be supposed in arterial hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12219870     DOI: 10.1016/s0895-7061(02)02967-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  Hormones and the heart: Does the cardiovascular system need growth hormone in adult life?

Authors:  Th B Twickler; M J M Cramer; P J Senden; W R de Vries; H P F Koppeschaar
Journal:  Neth Heart J       Date:  2003-04       Impact factor: 2.380

Review 2.  Oxidative stress and the ageing endocrine system.

Authors:  Giovanni Vitale; Stefano Salvioli; Claudio Franceschi
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

3.  Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke: The Framingham Study.

Authors:  Hamidreza Saber; Jayandra J Himali; Alexa S Beiser; Ashkan Shoamanesh; Aleksandra Pikula; Ronenn Roubenoff; Jose R Romero; Carlos S Kase; Ramachandran S Vasan; Sudha Seshadri
Journal:  Stroke       Date:  2017-06-08       Impact factor: 7.914

Review 4.  The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances.

Authors:  Zoltan Ungvari; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

Review 5.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

6.  Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians' offspring.

Authors:  Giovanni Vitale; Michael P Brugts; Giulia Ogliari; Davide Castaldi; Letizia M Fatti; Aimee J Varewijck; Steven W Lamberts; Daniela Monti; Laura Bucci; Elisa Cevenini; Francesco Cavagnini; Claudio Franceschi; Leo J Hofland; Daniela Mari; Joseph Janssen
Journal:  Aging (Albany NY)       Date:  2012-09       Impact factor: 5.682

7.  Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases.

Authors:  Irina D Strazhesko; Olga N Tkacheva; Dariga U Akasheva; Ekaterina N Dudinskaya; Ekaterina V Plokhova; Valentina S Pykhtina; Anna S Kruglikova; Natalia V Brailova; Natalia V Sharashkina; Daria A Kashtanova; Olesya Y Isaykina; Mariya S Pokrovskaya; Vladimir A Vygodin; Irina N Ozerova; Dmitry A Skvortsov; Sergey A Boytsov
Journal:  Front Genet       Date:  2017-12-15       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.